Quick Answer
Syndax Pharmaceuticals Inc reported Shares Outstanding of 87.41 million shares for fiscal year 2025.
Syndax Pharmaceuticals Inc Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 87.41M | +2.0% |
| 2024 | 85.69M | +1.0% |
| 2023 | 84.83M | +24.5% |
| 2022 | 68.11M | +23.9% |
| 2021 | 54.98M | +14.8% |
| 2020 | 47.88M | +76.4% |
| 2019 | 27.14M | +9.3% |
| 2018 | 24.84M | +1.8% |
| 2017 | 24.39M | +33.9% |
| 2016 | 18.22M | +21219.3% |
| 2015 | 85,440 | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 86.91M | +1.6% | +1.0% |
| June 30, 2025 | 86.06M | +1.2% | +0.0% |
| March 31, 2025 | 86.05M | +1.3% | +0.4% |
| December 31, 2024 | 85.69M | +1.0% | +0.1% |
| September 30, 2024 | 85.57M | +22.9% | +0.6% |
| June 30, 2024 | 85.03M | +22.5% | +0.1% |
| March 31, 2024 | 84.98M | +24.1% | +0.2% |
| December 31, 2023 | 84.83M | +24.5% | +21.8% |
- Syndax Pharmaceuticals Inc showed an increase of +2.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2015–2025 period, Syndax Pharmaceuticals Inc’s shares outstanding has grown by 102201.0% (from 85.4 thousand shares to 87.41 million shares).
- The most recent figure is from Syndax Pharmaceuticals Inc’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: